Helicobacter pylori is classified as a class I carcinogenic factor and its persistent colonization in the stomach induces gastric cancer. Cancerous Inhibitor of PP2A (CIP2A) is a newly identified oncoprotein overexpressed in gastric cancer. Serving as a key oncoprotein, CIP2A also participates in regulation of senescence and proliferation of gastric cells. The combination of aberrant CIP2A expression inducing unlimited cell proliferation, and H. pylori infection eliciting aberrant expression of some key proteins, results in the onset of gastric tumorigenesis. However, the relationship between H. pylori infection and CIP2A expression still remains undefined. The aim of our study was to verify the effect of H. pylori infection on CIP2A expression levels and identify H. pylori signalling molecules and corresponding pathways influencing CIP2A expression. Following plasmid-mediated expression of CagA in human gastric cell lines, the cells were infected with H. pylori and CIP2A expression levels were examined by immunoblotting. Signal inhibitors were used to verify which signal pathways were involved. We also performed CIP2A depletion and H. pylori infection after depletion in AGS cells. H. pylori infection-induced CIP2A expression was dependent on cagA gene expression and CagA phosphorylation. Bacterial oncoprotein CagA upregulated CIP2A expression and this upregulation effect was dependent on Src and Ras/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways. H. pylori infection-induced Myc stabilization was partially attenuated by CIP2A depletion. The results of our study provide further information for understanding the mechanism of H. pylori carcinogenesis.
INTRODUCTION
Helicobacter pylori has been defined as a class I carcinogenic factor by the World Health Organization and its persistent colonization in the stomach leads to an increased risk of peptic ulcers and gastric adenocarcinoma (Houghton & Wang, 2005; Peek & Blaser, 2002) . Some H. pylori strains contain a 35-40 kb cag pathogenicity island (PAI) encoded by 27-33 genes (Akopyants et al., 1998; Azuma et al., 2004) . One constituent of the cag PAI is cagA, which encodes a 120-140 kDa CagA protein. CagA protein, which has tyrosine phosphorylation (EPIYA) motifs, is injected into gastric epithelial cells by the type IV secretory system (TFSS) (Odenbreit et al., 2000; Stein et al., 2000) . cagApositive H. pylori strains have a closer association with the progress of both peptic ulcers and gastric cancer than cagAnegative strains according to epidemiological research (Hatakeyama, 2003) . Within gastric epithelial cells, tyrosine phosphorylation occurs at the C terminus of CagA by the Src family of tyrosine kinases (Kwok et al., 2007; Stein et al., 2002) . CagA interacts with many signal molecules and elicits a series of cellular events. These events include activation of the Ras/mitogen-activated protein (MAP) kinase kinase (MEK)/ extracellular signal-regulated kinase (ERK) pathway, bcatenin, Src kinase, the NF-kB pathway and the p38 MAP kinase pathway. Some changes related to cell morphology, cell scattering, cell proliferation and intercellular tight junctions have also been identified (Hatakeyama, 2003 (Hatakeyama, , 2004 Nguyen et al., 2008; Backert & Selbach, 2008; Backert & Meyer, 2006; Handa et al., 2007) . According to these observations, bacterial oncoprotein CagA participates in gastric tissue injury caused by cagA-positive H. pylori infection.
Unlimited cellular proliferation is a hallmark of tumours. Tumorigenesis is related to the disordered expression of some key factors which participate in the regulation of cell cycle progression, differentiation, apoptosis and senescence (Hanahan & Weinberg, 2000) . Recent studies have reported that CIP2A (Cancerous Inhibitor of PP2A) serves as an important oncoprotein (Junttila et al., 2007) . Protein phosphatase 2A (PP2A) can facilitate the proteolytic degradation of oncoprotein Myc and prevent malignant cell growth (Yeh et al., 2004) . CIP2A stabilizes Myc protein through inhibiting PP2A activity and promotes tumour formation in vivo (Junttila et al., 2007) . Moreover, transformation of immortalized human cells is observed when CIP2A is overexpressed (Junttila et al., 2007) . More importantly, overexpression of CIP2A has been observed in gastric cancer (Li et al., 2008) . Using small interfering RNA (siRNA) to knock down CIP2A expression inhibits cell growth and clone formation, and promotes senescence in gastric cancer-derived AGS cell lines (Li et al., 2008) . Taken together, CIP2A is a newly identified oncoprotein in gastric tissues, and may serve as a diagnostic marker and therapeutic target for gastric tumours (Li et al., 2008 ).
As mentioned above, H. pylori infection could affect the expression level of gastric carcinogenic factors, such as Myc (Zhu et al., 2008) , b-catenin (Franco et al., 2005) and cyclin D1 (Chang et al., 2006) . However, up to now, the relationship between H. pylori infection and CIP2A expression has never been studied. However, both bacterial oncoprotein CagA and cellular oncoprotein CIP2A expression have been associated with gastric carcinogenesis. To figure out the effect of CagA on CIP2A may help us to understand the carcinogenic mechanism of H. pylori infection and the functional role of CIP2A in human gastric tumorigenesis. In order to elucidate the relationship between these two factors, we designed H. pylori infection and CagA transfection in gastric cells and tried to investigate whether main virulence factor CagA of H. pylori could increase the expression of oncoprotein CIP2A in cell lines. Furthermore, we used signal inhibitors to examine which pathway was involved in the CagA-mediated regulation of CIP2A expression.
METHODS
H. pylori and bacterial culture. The H. pylori strains used in this study were cagA-and vacA-positive standard strains (NCTC 11637 and 26695 11637 were constructed within strains 11637 and 26695 by insertional mutagenesis using the piLL570 vector. All strains were grown in Brucella broth with 5 % fetal bovine serum (FBS) under microaerobic conditions (5 % O 2 , 10 % CO 2 , 85 % N 2 ) at 37 uC, harvested by centrifugation, and added to gastric cells at a bacteria-to-cell ratio of 100 : 1.
Plasmid. Wild-type (WT) cagA/pcDNA3.1(+) plasmid (WT-cagA) and a phosphorylation-resistant (PR) plasmid derivative (PR-cagA) were kindly provided by Zhu Yongliang (Zhejiang University, China). These two plasmids were characterized as described previously (Zhu et al., 2004 (Zhu et al., , 2005 . The pcDNA3.1(+) mammalian expression vector was purchased from Invitrogen.
Cell lines and culture conditions. The human gastric epithelial AGS cells and immortalized GES-1 cells were maintained in our laboratory. AGS gastric cancer cells were cultured in F12 medium (Gibco Life Technologies) with 10 % FBS (Gibco Life Technologies). GES-1 cells were cultured in RPMI 1640 medium (Gibco Life Technologies) with 10 % newborn bovine serum (Gibco Life Technologies). All cells were cultured in 5 % CO 2 -air at 37 uC.
Transfection of AGS and GES-1 cells. FuGENE HD Transfection Reagent (Roche Applied Science) was used to transfect plasmid WTcagA, PR-cagA or pcDNA3.1 blank vector into 5610 5 AGS or GES-1 cells in six-well plates. All transfection procedures were performed according to the manufacturers and all experiments were repeated three times. After the transfection, cells were harvested and lysed using cell lysis buffer (Beyotime) supplemented with protease inhibitors (Complete Mini; Roche Applied Science) before freezing at 280 uC. In order to investigate the signal pathways in the epithelial cells, we used the following reagents: BAY11-7082 (5 mM), PP1 (20 mM), PD98059 (50 mM) and SB203580 (10 mM) (all from Invitrogen). We used one of these reagents to pre-incubate cells for 30 min, and then transfected plasmids into cells. Protein collection methods were the same as without exposure to signal blocking reagents.
Western blot analysis. We used a BCA reagent kit (Merck) to measure protein concentrations and standardized samples in Western blot analysis according to the protein concentrations. Protein samples were separated by SDS-PAGE (8 % SDS-acrylamide gels), and then proteins were transferred to a nitrocellulose membrane. After that, the membranes were incubated in the blocking buffer (TBS containing 0.1 % Tween, 5 % nonfat powdered milk) for 1.5 h, and immunoblotted for 1.5 h with antibodies against Myc, b-actin, C-CagA (Santa Cruz Biotechnologies) or CIP2A (Novus Biologicals). Membranes were then washed three times with TBS-Tween solution and incubated with the corresponding antibodies conjugated to horseradish peroxidase for 50 min. We then washed the membranes three times with TBS-Tween and used the Chemilucent ECL Detection System (Millipore) to detect the signals. Bio-Rad Quantity One 1-D Analysis software was used to analyse the Western blot results.
siRNA experiments. The siRNA targeting CIP2A and control siRNA were purchased from Invitrogen. The siRNA sequence for CIP2A was 59-GACAACUGUCAAGUGUACCACUCUU-39. Lipofectamine 2000 (Invitrogen) was used to transfect the gastric cells with siRNA.
Statistical analysis of data. The Statistical Package for the Social Sciences (SPSS) was used in the statistical analysis, and a Student's t test was used to determine statistical significance. P-values ,0.05 were considered statistically significant.
RESULTS AND DISCUSSION
Effect of H. pylori infection on CIP2A expression level in AGS cells H. pylori is a human gastric carcinogenic pathogen and CIP2A is a newly identified oncoprotein in gastric cancer (Li et al., 2008; Khanna et al., 2009) . To elucidate whether H. pylori upregulated CIP2A expression, we designed H. pylori infection in human gastric epithelium AGS cells. AGS cells were incubated with H. pylori strain 26695 for 0.5, 1, 1.5 and 2 h, at a quantity of 100 bacteria per cell. Total cellular protein analysed by Western blotting indicated that the CIP2A expression level was elevated after infection for all time points compared to the expression in normal AGS cells, but that the effect was not remarkably timedependent (Fig. 1a) (Fig. 1b) . However, there was no significant increase in CIP2A expression level in AGS cells infected with strain cagA 2 26695 and strain cagA 2 11637 compared to the expression in normal AGS cells (Fig. 1b) . Taken together, H. pylori infection increased CIP2A expression in AGS cells, and this effect was not dependent on infection time but dependent on expression of the bacterial cagA gene.
CIP2A expression in AGS and GES-1 cells transfected with plasmid WT-cagA or PR-cagA As CIP2A expression was demonstrated to be associated with CagA expression of H. pylori, we next evaluated the relationship between CagA and CIP2A in the absence of H. pylori infection. AGS and GES-1 cells were transfected with plasmid WT-cagA or PR-cagA. The PR-cagA plasmid encodes a CagA protein with a mutation in the EPIYA motif, required for CagA tyrosine phosphorylation. Thus the PR-CagA mutant protein cannot be phosphorylated nor can it transmit the signal pathway (Zhu et al., 2004 (Zhu et al., , 2005 Yokoyama et al., 2005) . After 36 h transfection, the CIP2A expression level in AGS and GES-1 cells expressing WT-CagA was significantly greater than that in normal cells and cells transfected with blank vector (Fig. 2a) . In contrast, there was no increase in CIP2A expression level in AGS and GES-1 cells transfected with vector expressing PR-CagA compared with cells alone or blank vector (Fig. 2b) . Moreover, the Myc expression level was also elevated in cells expressing WTCagA (Fig. 2a) . Antibody against C-CagA ensured that WTcagA and PR-cagA plasmid transfections and CagA protein expression were accomplished as expected (Fig. 2a, b) . Taken together, bacterial oncoprotein CagA can upregulate the expression of CIP2A and this effect is closely dependent on the tyrosine phosphorylation of CagA.
Signal inhibitor effects on CIP2A expression in AGS cells transfected with WT-cagA plasmid
After translocating into epithelial cells through the TFSS, H. pylori CagA protein is known to activate the MEK/ERK pathway, Src kinase, the NF-kB pathway and the p38 MAP kinase pathway regardless of its tyrosine phosphorylation CIP2A is upregulated by H. pylori CagA status. In order to elucidate which pathway participated in the upregulation of CIP2A by CagA, we used the MAP kinase inhibitor PD98059 to block MEK1 kinase activity, thereby inhibiting ERK1/2 phosphorylation (Alessi et al., 1995) , SB203580 to block p38 kinase activity (Young et al., 1997) , BAY11-7082 to inhibit the NF-kB pathway (Pierce et al., 1997) and PP1 to block Src-family tyrosine kinase activity (Hanke et al., 1996) . Each signal inhibitor was incubated with gastric cells for 30 min prior to plasmid transfection. After 36 h transfection, while CIP2A upregulation by CagA was attenuated by PP1 (Src kinase) and PD98059 (MEK1), CIP2A upregulation was maintained using SB203580 (P38) and BAY11-7082 (NF-kB) (Fig. 3) . In total, the results indicated that Src kinase and MEK/ERK pathways participated in CIP2A upregulation by CagA. In AGS cells, CagA protein was tyrosine phosphorylated by Src kinase, thereafter promoting the activated MEK/ERK pathway to upregulate CIP2A expression (Backert & Selbach, 2008) .
Effect of CIP2A depletion and H. pylori infection on Myc expression in AGS cells
It has been reported that CIP2A depletion causes the downregulation of Myc expression in several cell lines (Li et al., 2008) . To investigate whether H. pylori infection could still upregulate Myc expression in AGS cells depleted of CIP2A, we performed siRNA-mediated CIP2A depletion and H. pylori strain 26695 infection after depletion in AGS cells. We found that the Myc expression level was higher in cells treated with CIP2A depletion and H. pylori infection than in cells only treated with CIP2A depletion, and this level was lower in cells treated with CIP2A depletion and H. pylori infection than in those only treated with H. pylori infection (Fig. 4) . The results suggest that H. pylori infection-induced Myc stabilization was partially attenuated by CIP2A depletion.
CIP2A has recently been observed to be overexpressed in head and neck squamous cell carcinoma, colon cancer (Junttila et al., 2007) and gastric cancer (Li et al., 2008) . CIP2A overexpression stabilized the Myc protein (Khanna et al., 2009) . The depletion of CIP2A inhibited growth and clonogenic capabilities, and induced senescence of AGS cells (Li et al., 2008) . CIP2A is also known to act as an endogenous PP2A inhibitor (Junttila et al., 2007) . H. pylori, a human gastric carcinogenic pathogen, has been classified as a class I carcinogenic factor by the World Health Organization and its long-term colonization in stomach initiates an increased risk of gastric cancer. Recent in vitro or in vivo data have demonstrated that H. pylori infection can upregulate cyclin D1 expression, stabilize Myc protein, increase b-catenin nuclear accumulation and induce release of cytokines such as interleukin-8 and CCL20 (Chang et al., 2006; Yang et al., 2003; Zhu et al., 2008; Franco et al., 2005; Kim et al., 2006; Tomimori et al., 2007) . The expression level of murine double minute 2 was higher in gastric cancer than in chronic gastritis in H. pylori-infected gastric mucosa (Nakajima et al., 2009) . However, up to now, the relationship between gastric carcinogenic pathogen H. pylori infection and gastric cancer oncoprotein CIP2A expression has never been studied. Thus we have explored the relationship between H. pylori infection, CIP2A expression and signalling pathways leading to gastric cancer. Some former studies showed that H. pylori infection could upregulate cyclooxygenase 2 expression in vitro (Seo et al., 2007; Li et al., 2009) . In our study, we verified that CIP2A expression in AGS cells was stimulated by H. pylori infection, and that this upregulation effect was not dependent on infection time but dependent on the cagA gene status of bacterial strains (Fig. 1) . Kim et al. (2006) found that H. pylori CagA transfection of gastric epithelial cells induced IL-8 production, and Franco et al. (2005) found that CagA transfection increased b-catenin nuclear accumulation. In our study, we demonstrated that the CIP2A expression level was elevated by CagA transfection and that this elevation only occurred after tyrosine phosphorylation of CagA (Fig. 2) . Moreover, Khanna et al. (2009) reported that Myc directly promoted CIP2A gene expression. Surprisingly, we found that CagA transfection also increased the Myc expression level (Fig. 2) . These results offered more credible evidence for upregulation of CIP2A expression by CagA transfection. After translocation into epithelial cells, H. pylori CagA protein could activate four major pathways, including the MEK/ERK pathway, Src kinase, the NF-kB pathway and the p38 MAP kinase pathway (Backert & Selbach, 2008) . It was previously shown that signal inhibitors could be used to elucidate which pathway was involved in CagA-induced IL-8 production (Kim et al., 2006) or H. pylori infectioninduced cyclooxygenase 2 upregulation (Li et al., 2009) . By using four corresponding signal inhibitors, we identified that Src kinase and MEK/ERK pathways were involved in CIP2A upregulation by CagA (Fig. 3) . Taken together, CagA protein was tyrosine-phosphorylated by Src kinase, and thereafter activated the MEK/ERK pathway to upregulate CIP2A expression in AGS cells. We also found that H. pylori infection-induced Myc stabilization was partially dependent on CIP2A expression, and CIP2A depletion caused increased Myc degradation (Fig. 4) .
The combination of data from our research and others led us to propose the signalling mechanism outlined in Fig. 5 . Kim et al. (2006) reported that CagA transfection activated Src kinase, and Zhu et al. (2007) proved that CagA transfection and phosphorylated CagA protein (P-CagA) activated the ERK1/2 pathway. Based on these two findings, we used two corresponding signal inhibitors to block Src kinase or MEK1 kinase, and figured out the following mechanisms. After translocating into gastric epithelial cells through the TFSS, bacterial oncoprotein CagA was tyrosine-phosphorylated by Src kinase. After CIP2A is upregulated by H. pylori CagA that, P-CagA activated the MEK/ERK pathway and upregulated gastric oncoprotein CIP2A expression. Upregulation of CIP2A expression by H. pylori provided a further explanation for the gastric carcinogenic effects of H. pylori infection.
Overall, this is the first time that the mechanism by which H. pylori infection and bacterial oncoprotein CagA upregulated CIP2A expression in gastric cell lines has been elucidated. CagA protein activated the Src and MEK/ERK signal pathways, resulting in the elevation of expression of CIP2A protein in AGS cells. This work has contributed to understanding the mechanism by which gastric tumours are caused by H. pylori infection in humans. 
